MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced U.S. Food and ...
Atrial fibrillation is a common heart condition characterized by a rapid, irregular heartbeat stemming from the heart's upper ...
If you sometimes experience a racing or irregular heartbeat, it may be caused by atrial fibrillation (AFib), the most common type of heart arrhythmia. AFib can make you five times more likely to have ...
- A new, first-of-its-kind study known as TAP-CHF leverages expertise across Abbott's cardiovascular portfolio to optimize treatment for patients suffering from both AFib and heart failure - The trial ...
What Is Rate Control for Atrial Fibrillation? Rate control is not a cure for AFib, but a way of keeping your heart rate in check. It’s done with medications that keep your heart from beating too ...
Medtronic could have a big year in the atrial fibrillation treatment (Afib) space. The Dublin-based company began to show this might well be the case when it announced FDA greenlit the DiamondTemp ...
FDA approval results in the only label of its kind for more than 3 million patients in the United States, significantly expanding AtriCure’s addressable market Superiority trial showed a 29% ...